NCT03155113View on ClinicalTrials.gov

Role of the Host Immunity in the Non-response to Direct Anti-viral Agent (DAA) Therapy

NACompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

August 30, 2017

Primary Completion Date

October 31, 2019

Study Completion Date

December 31, 2019

Conditions
Chronic Hepatitis C
Interventions
OTHER

blood drawing

Before starting therapy a blood sample will be collected from any subject.

Trial Locations (1)

43126

Unit of Infectious Diseases and Hepatology, Parma

Sponsors

Collaborators (1)

AbbVie
All Listed Sponsors
collaborator

AbbVie

INDUSTRY

lead

Azienda Ospedaliero-Universitaria di Parma

OTHER